Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomedical Engineers Reveal Organ-on-Chip Device for Drug Testing and Organ Repair

By LabMedica International staff writers
Posted on 21 Mar 2016
A soft, biodegradable polymer was used to form a three-dimensional organ-on-chip device for growth of artificial organs that could be used for drug testing or the repair or replacement of damaged organs.

Poly(octamethylene maleate (anhydride) citrate) (POMaC) is a soft, biodegradable elastomer with the potential to be a good biomaterial for use in scaffolds for soft tissue engineering. More...
POMaC is notable for its dual cross-linking mechanism that allows the engineer to manipulate the resultant mechanical properties of the material during preparation.

Investigators at the University of Toronto (Canada) used POMaC to fashion "AngioChip" scaffolds comprising a series of thin layers about 50 to 100 micrometers wide, stamped with a pattern of nanopore and micro-hole channels. The layers, which resembled computer microchips, were then stacked into a three-dimensional structure of synthetic blood vessels. The scaffold was bathed in media containing living cells. The cells rapidly attached to the inside and outside of the channels and began growing.

The investigators reported in the March 7, 2016, online edition of the journal Nature Materials that incorporation of nanopores and micro-holes in the vessel walls enhanced permeability, and permitted intercellular crosstalk and extravasation of monocytes and endothelial cells on biomolecular stimulation. They also showed that vascularized hepatic tissues and cardiac tissues engineered by using AngioChips processed clinically relevant drugs delivered through the vasculature, and that millimeter-thick cardiac tissues could be engineered in a scalable manner. Furthermore, AngioChip cardiac tissues implanted into the femoral vessels of rat hindlimbs established immediate blood perfusion.

"It is a fully three-dimensional structure complete with internal blood vessels," said senior author Dr. Milica Radisic, professor of biomedical engineering at the University of Toronto. "It behaves just like vasculature, and around it there is a lattice for other cells to attach and grow. Previously, people could only do this using devices that squish the cells between sheets of silicone and glass. You needed several pumps and vacuum lines to run just one chip. Our system runs in a normal cell culture dish, and there are no pumps; we use pressure heads to perfuse media through the vasculature. The wells are open, so you can easily access the tissue. Our liver actually produced urea and metabolized drugs."

Related Links:

University of Toronto



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.